215 related articles for article (PubMed ID: 32343311)
1. A splice site-sensing conformational switch in U2AF2 is modulated by U2AF1 and its recurrent myelodysplasia-associated mutation.
Warnasooriya C; Feeney CF; Laird KM; Ermolenko DN; Kielkopf CL
Nucleic Acids Res; 2020 Jun; 48(10):5695-5709. PubMed ID: 32343311
[TBL] [Abstract][Full Text] [Related]
2. Cancer-Associated Mutations Mapped on High-Resolution Structures of the U2AF2 RNA Recognition Motifs.
Glasser E; Agrawal AA; Jenkins JL; Kielkopf CL
Biochemistry; 2017 Sep; 56(36):4757-4761. PubMed ID: 28850223
[TBL] [Abstract][Full Text] [Related]
3. Recognition of the 3' splice site RNA by the U2AF heterodimer involves a dynamic population shift.
Voith von Voithenberg L; Sánchez-Rico C; Kang HS; Madl T; Zanier K; Barth A; Warner LR; Sattler M; Lamb DC
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7169-E7175. PubMed ID: 27799531
[TBL] [Abstract][Full Text] [Related]
4. Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation.
Akef A; McGraw K; Cappell SD; Larson DR
PLoS Biol; 2020 Nov; 18(11):e3000920. PubMed ID: 33137094
[TBL] [Abstract][Full Text] [Related]
5. Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies.
Biancon G; Joshi P; Zimmer JT; Hunck T; Gao Y; Lessard MD; Courchaine E; Barentine AES; Machyna M; Botti V; Qin A; Gbyli R; Patel A; Song Y; Kiefer L; Viero G; Neuenkirchen N; Lin H; Bewersdorf J; Simon MD; Neugebauer KM; Tebaldi T; Halene S
Mol Cell; 2022 Mar; 82(6):1107-1122.e7. PubMed ID: 35303483
[TBL] [Abstract][Full Text] [Related]
6. A synthetic small molecule stalls pre-mRNA splicing by promoting an early-stage U2AF2-RNA complex.
Chatrikhi R; Feeney CF; Pulvino MJ; Alachouzos G; MacRae AJ; Falls Z; Rai S; Brennessel WW; Jenkins JL; Walter MJ; Graubert TA; Samudrala R; Jurica MS; Frontier AJ; Kielkopf CL
Cell Chem Biol; 2021 Aug; 28(8):1145-1157.e6. PubMed ID: 33689684
[TBL] [Abstract][Full Text] [Related]
7. U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing.
Okeyo-Owuor T; White BS; Chatrikhi R; Mohan DR; Kim S; Griffith M; Ding L; Ketkar-Kulkarni S; Hundal J; Laird KM; Kielkopf CL; Ley TJ; Walter MJ; Graubert TA
Leukemia; 2015 Apr; 29(4):909-17. PubMed ID: 25311244
[TBL] [Abstract][Full Text] [Related]
8. Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal.
Glasser E; Maji D; Biancon G; Puthenpeedikakkal AMK; Cavender CE; Tebaldi T; Jenkins JL; Mathews DH; Halene S; Kielkopf CL
Nucleic Acids Res; 2022 May; 50(9):5299-5312. PubMed ID: 35524551
[TBL] [Abstract][Full Text] [Related]
9. Representative cancer-associated U2AF2 mutations alter RNA interactions and splicing.
Maji D; Glasser E; Henderson S; Galardi J; Pulvino MJ; Jenkins JL; Kielkopf CL
J Biol Chem; 2020 Dec; 295(50):17148-17157. PubMed ID: 33020180
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of the aberrant 3' splice site selection by cancer-associated mutations on the U2AF1.
Yoshida H; Park SY; Sakashita G; Nariai Y; Kuwasako K; Muto Y; Urano T; Obayashi E
Nat Commun; 2020 Sep; 11(1):4744. PubMed ID: 32958768
[TBL] [Abstract][Full Text] [Related]
11. Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene
Fei DL; Zhen T; Durham B; Ferrarone J; Zhang T; Garrett L; Yoshimi A; Abdel-Wahab O; Bradley RK; Liu P; Varmus H
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10437-E10446. PubMed ID: 30322915
[TBL] [Abstract][Full Text] [Related]
12. Mutant U2AF1-induced alternative splicing of H2afy (macroH2A1) regulates B-lymphopoiesis in mice.
Kim SP; Srivatsan SN; Chavez M; Shirai CL; White BS; Ahmed T; Alberti MO; Shao J; Nunley R; White LS; Bednarski J; Pehrson JR; Walter MJ
Cell Rep; 2021 Aug; 36(9):109626. PubMed ID: 34469727
[TBL] [Abstract][Full Text] [Related]
13. U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
Zhu Y; Song D; Guo J; Jin J; Tao Y; Zhang Z; Xu F; He Q; Li X; Chang C; Wu L
Cell Death Dis; 2021 Jun; 12(7):655. PubMed ID: 34183647
[TBL] [Abstract][Full Text] [Related]
14. Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.
Jenkins JL; Kielkopf CL
Trends Genet; 2017 May; 33(5):336-348. PubMed ID: 28372848
[TBL] [Abstract][Full Text] [Related]
15. HNRNPA1 promotes recognition of splice site decoys by U2AF2 in vivo.
Howard JM; Lin H; Wallace AJ; Kim G; Draper JM; Haeussler M; Katzman S; Toloue M; Liu Y; Sanford JR
Genome Res; 2018 May; 28(5):689-698. PubMed ID: 29650551
[TBL] [Abstract][Full Text] [Related]
16. Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome.
Shirai CL; White BS; Tripathi M; Tapia R; Ley JN; Ndonwi M; Kim S; Shao J; Carver A; Saez B; Fulton RS; Fronick C; O'Laughlin M; Lagisetti C; Webb TR; Graubert TA; Walter MJ
Nat Commun; 2017 Jan; 8():14060. PubMed ID: 28067246
[TBL] [Abstract][Full Text] [Related]
17. A UHM-ULM interface with unusual structural features contributes to U2AF2 and SF3B1 association for pre-mRNA splicing.
Galardi JW; Bela VN; Jeffery N; He X; Glasser E; Loerch S; Jenkins JL; Pulvino MJ; Boutz PL; Kielkopf CL
J Biol Chem; 2022 Aug; 298(8):102224. PubMed ID: 35780835
[TBL] [Abstract][Full Text] [Related]
18. U2AF65 adapts to diverse pre-mRNA splice sites through conformational selection of specific and promiscuous RNA recognition motifs.
Jenkins JL; Agrawal AA; Gupta A; Green MR; Kielkopf CL
Nucleic Acids Res; 2013 Apr; 41(6):3859-73. PubMed ID: 23376934
[TBL] [Abstract][Full Text] [Related]
19. In vitro iCLIP-based modeling uncovers how the splicing factor U2AF2 relies on regulation by cofactors.
Sutandy FXR; Ebersberger S; Huang L; Busch A; Bach M; Kang HS; Fallmann J; Maticzka D; Backofen R; Stadler PF; Zarnack K; Sattler M; Legewie S; König J
Genome Res; 2018 May; 28(5):699-713. PubMed ID: 29643205
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis.
Gurule NJ; Malcolm KC; Harris C; Knapp JR; O'Connor BP; McClendon J; Janssen WJ; Lee FFY; Price C; Osaghae-Nosa J; Wheeler EA; McMahon CM; Pietras EM; Pollyea DA; Alper S
Leukemia; 2023 Oct; 37(10):2115-2124. PubMed ID: 37591942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
